Multi4 is developing advanced endoscopic technology aimed at improving cancer diagnosis and treatment by making procedures more precise and less invasive. The company is focused on product development, validation, and preparing its technology for clinical adoption in the regulated medtech market. With the recent SEK 29M (~€2.6M) funding round, Multi4 plans to accelerate development and move closer to broader clinical use. The funding round brought both capital and experienced angel investors who add healthcare, medtech, and commercial expertise. Multi4 is based in Jönköping and is positioning its technology at the intersection of precision medicine and scalable oncology care.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2026